Clinical Trials Directory

Trials / Unknown

UnknownNCT03226314

Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island

Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae (Prevalence, Resistance Mechanisms and Risk Factors) in Reunion Island

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In its report dated april 2014, World Health Organization confirms antibiotic resistance dissemination in all parts of the world, in hospitals and in community and worries about a possible comeback to a pre-antibiotic era during the 21st century. For the last 15 years, third-generation cephalosporins resistant enterobacteriaceae (3GCREB) prevalence is continuously increasing. Community 3GCREB prevalence has not been studied whereas several observations made in Reunion Island hospital suggest a diffusion in community. In this situation of world-wide and regional extension of bacterial resistance, the investigator offers to study bacterial resistance to antibiotic in Reunion Island community.

Detailed description

The investigator is focused on E. coli species exhibiting BLSE or metallo-betalactamases production that could be encountered du to the increasing level of migratory flow in Reunion Island. Fecal sample collection will be used for further investigations on bacterial typology.

Conditions

Interventions

TypeNameDescription
PROCEDUREstool samplestudy will be proposed to all patients entering emergency ward or intensive care unit in Reunion Island university hospital. Upon consent, a stool sample will be taken (either directly on emitted stools or by rectal sampling) and analysed for enterobacteriaceae.

Timeline

Start date
2017-11-21
Primary completion
2018-12-01
Completion
2019-06-30
First posted
2017-07-21
Last updated
2019-03-07

Locations

1 site across 1 country: Reunion

Source: ClinicalTrials.gov record NCT03226314. Inclusion in this directory is not an endorsement.